SAN FRANCISCO, Oct. 30, 2019 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter on Wednesday, November 6, 2019, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a conference call to revi

PHILADELPHIA, Oct. 30, 2019 /PRNewswire/ -- Vantage EyeCare, LLC is pleased to announce the addition of Dr. Allen Richmond to its Northe

NEWARK, Calif., Oct. 30, 2019 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that the first patient has been dosed in a Phase 2 study of PTG-300 in patients with polycythemia vera (PV), a myeloproliferative disorder characterized by overproduction of red blood cells."In addition to our ongoing study of PTG-300 in patients with beta-th

WASHINGTON, Oct. 30, 2019 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, announces the launch of the #ChangeLungCancer social media campaign.  LUNGevity is proud to provide a new way for lung cancer advocates to get involved this November during Lung Cancer Awareness Month through this social media campaig

WASHINGTON, Oct. 30, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the third quarter 2019 and provide a general business overview, on Wednesday, November 6, 2019, after the market closes.  Vanda will host a conference call at 4:30 PM ET on

FLINT, Mich., Oct. 30, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) will release its third-quarter 2019 operating results before market open Tuesday, Nov. 12. A conference call and live webcast will be held at 8:30 a.m. ET.

ARLINGTON, Va., Oct. 30, 2019 /PRNewswire/ -- Edward Price, President and CEO, SEQENS N.A. and a member of SOCMA's

IRVINE, Calif., Oct. 30, 2019 /PRNewswire/ -- Healthpeak Properties, Inc., formerly known as HCP, Inc. (NYSE: HCP, to become "PEAK" effective November 5, 2019), today announced results for the third quarter ended September 30, 2019. For the quarter, Healthpeak generated a net loss of $0.09 per share, N

IRVINE, Calif., Oct. 30, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) announced today that it has changed its name to Healthpeak Properties, Inc. ("Healthpeak"), effective today. Healthpeak's common stock is expected to begin trading under its new name and ticker symbol "PEAK" on the New York Stock Exchange at the opening of trading on Nove

PORTLAND, Maine, Oct. 30, 2019 /PRNewswire/ -- Medicare beneficiaries living in Maine and New Hampshire have access to one of the very few Medicare Advantage contracts in the country to earn 5 out of 5 Stars from the Centers for Medicare and Medicaid Services (CMS) for 2020. Portl